---
figid: PMC4313785__fendo-06-00012-g001
figtitle: Figitumumab (CP) is a biased agonist of the IGF1R that selectively promotes
  Beta-arrestin1 (Beta-arr1) signaling in cancer cells
organisms:
- NA
pmcid: PMC4313785
filename: fendo-06-00012-g001.jpg
figlink: /pmc/articles/PMC4313785/figure/F1/
number: F1
caption: Figitumumab (CP) is a biased agonist of the IGF1R that selectively promotes
  β-arrestin1 (β-arr1) signaling in cancer cells. (A) IGF1 binding to and activation
  of the IGF1R stimulates the β-arr1 pathway that leads to proteasomal degradation
  of the IGF1R through a ubiquitin (Ub)-mediated mechanism and ERK activation. IGF1
  binding to the IGF1R also induces IGF1R autophosphorylation and this serves to increase
  the kinase pathway that promotes the phosphorylation and activation of AKT. (B)
  CP binding to the IGF1R preferentially increases β-arr1 signaling, and inhibits
  the IGF1R kinase pathway. By this mechanism, CP downregulates IGF1R and AKT signaling,
  and increases ERK-mediated mitogenic signaling.
papertitle: 'Insulin/Insulin-Like Growth Factors in Cancer: New Roles for the Aryl
  Hydrocarbon Receptor, Tumor Resistance Mechanisms, and New Blocking Strategies.'
reftext: Travis B. Salisbury, et al. Front Endocrinol (Lausanne). 2015;6:12.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8372252
figid_alias: PMC4313785__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC4313785__F1
ndex: d14f769f-df1e-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4313785__fendo-06-00012-g001.html
  '@type': Dataset
  description: Figitumumab (CP) is a biased agonist of the IGF1R that selectively
    promotes β-arrestin1 (β-arr1) signaling in cancer cells. (A) IGF1 binding to and
    activation of the IGF1R stimulates the β-arr1 pathway that leads to proteasomal
    degradation of the IGF1R through a ubiquitin (Ub)-mediated mechanism and ERK activation.
    IGF1 binding to the IGF1R also induces IGF1R autophosphorylation and this serves
    to increase the kinase pathway that promotes the phosphorylation and activation
    of AKT. (B) CP binding to the IGF1R preferentially increases β-arr1 signaling,
    and inhibits the IGF1R kinase pathway. By this mechanism, CP downregulates IGF1R
    and AKT signaling, and increases ERK-mediated mitogenic signaling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1
  - CP
  - IRS1
  - EPHB2
  - MAPK1
  - MAPK3
  - IGF1R
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
---
